Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized Double Blinded Phase 2b Clinical Trial Comparing Standard Dose With Two Higher Doses of Rifampicin for Treatment of Adults With Tuberculous Meningitis

NCT02169882 is registered in ClinicalTrials.gov with Universitas Padjadjaran as lead sponsor.

NCT NCT02169882
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02169882 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized Double Blinded Phase 2b Clinical Trial Comparing Standard Dose With Two Higher Doses of Rifampicin for Treatment of Adults With Tuberculous Meningitis
Lead sponsor
Universitas Padjadjaran
Phase
Phase 2/3
Overall status
Completed
Start date
December 1, 2014
Completion date
May 5, 2017
Enrollment
60 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

tuberculosis, meningeal